Pluripotent teratocarcinoma-thymus somatic cell hybrids

Area of Science:

• Developmental biology
• Cell biology
• Genetics

Background:

• Embryonal carcinoma (EC) cells are pluripotent and can differentiate into various cell types.
• Somatic cell hybridization is a technique used to study cell differentiation and genome function.

Purpose of the Study:

• To investigate whether fusion of pluripotent EC cells with differentiated somatic cells affects the EC cells' pluripotency.
• To determine if a complete diploid genome from a differentiated cell abolishes pluripotency in EC cells.

Main Methods:

• Fusion of PCC4aza1 embryonal carcinoma cells with thymocytes from young adult mice to create somatic cell hybrids.
• Tumorigenesis studies of these hybrids in immunodeficient (nu/nu) and syngeneic mice.
• Analysis of tumor composition for differentiated and EC-like tissues, and alpha-fetoprotein production.

Main Results:

• All tumors formed by the hybrids contained a mixture of differentiated tissues and embryonal carcinoma-like tissues.
• Some tumors exhibited alpha-fetoprotein production, a marker of pluripotency.
• The fusion process did not lead to a complete loss of pluripotency in the EC cell component.

Conclusions:

• Pluripotency of embryonal carcinoma cells can be maintained following hybridization with differentiated somatic cells.
• The introduction of a complete diploid genome from a differentiated cell does not necessarily abrogate the developmental potential of EC cells.
• These findings challenge the notion that genome-wide differentiation inherently leads to irreversible loss of pluripotency.